Breakthrough in Schizophrenia Research by Foundation's 2011 Outstanding Prizewinner
November 09, 2011
Joel E. Kleinman, M.D., Ph.D., the Foundation’s 2011 Lieber Prizewinner for Schizophrenia Research, led groundbreaking research which involved, for the first time, mapping brain development across different stages of life by changes in gene expression. The results of these studies, which involved the analysis of post-mortem brain tissue, were published in the October 26, 2011 issue of Nature Magazine. The findings shed light on the pathology and risk factors for severe mental illnesses like schizophrenia. “Ultimately, we want to find targets for treatment; this lets you take the first step in understanding how genetic variants increase risk for any brain disease,” Kleinman said.
Watch Dr. Kleinman's Outstanding Achievement Prize Video:
Meet our scientists
"In my case, this means having the chance to develop and test novel treatments."
Article comments
You have mentioned very interesting points! ps decent web site.
As a layman i have been hearing about breakthrough in Schizophrenia research. Except for Clozapine drug therapy, I find none of them are making it to the welfare and better life for Schizophrenics.
Add new comment